tiprankstipranks
Altamira Therapeutics (CYTOF)
OTHER OTC:CYTOF
US Market

Altamira Therapeutics (CYTOF) Technical Analysis

Compare
599 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
4Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Altamira Therapeutics’s (CYTOF) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Altamira Therapeutics is a Sell.
Altamira Therapeutics’s (CYTOF) 20-Day exponential moving average is 0.12, while Altamira Therapeutics’s (CYTOF) share price is $0.1, making it a Sell.
Altamira Therapeutics’s (CYTOF) 50-Day exponential moving average is 0.18, while Altamira Therapeutics’s (CYTOF) share price is $0.1, making it a Sell.

Altamira Therapeutics (CYTOF) Pivot Points

Mar 04, 2025, 04:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.08
0.09
0.09
0.11
0.11
0.12
0.13
Fibonacci
0.09
0.10
0.10
0.11
0.11
0.12
0.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Altamira Therapeutics (CYTOF) Moving Averages

Mar 04, 2025, 04:09 AM
Period
Simple
Exponential
MA5
0.11Sell
0.11Sell
MA10
0.12Sell
0.11Sell
MA20
0.12Sell
0.12Sell
MA50
0.15Sell
0.18Sell
MA100
0.33Sell
0.35Sell
MA200
0.72Sell
0.74Sell
Altamira Therapeutics’s (CYTOF) 10-Day exponential moving average is 0.11, while Altamira Therapeutics’s (CYTOF) share price is $0.1, making it a Sell.
Altamira Therapeutics’s (CYTOF) 100-Day exponential moving average is 0.35, while Altamira Therapeutics’s (CYTOF) share price is $0.1, making it a Sell.
Altamira Therapeutics’s (CYTOF) stock price is $0.1 and Altamira Therapeutics’s (CYTOF) 50-day simple moving average is 0.15, creating a Sell signal.
Altamira Therapeutics’s (CYTOF) stock price is $0.1 and Altamira Therapeutics’s (CYTOF) 100-day simple moving average is 0.33, creating a Sell signal.
Altamira Therapeutics’s (CYTOF) stock price is $0.1 and Altamira Therapeutics’s (CYTOF) 200-day simple moving average is 0.72, creating a Sell signal.

Altamira Therapeutics (CYTOF) Technical Indicators

Mar 04, 2025, 04:09 AM
Name
Value
Implied Action
RSI (14)
42.32
Neutral
STOCH (9,6)
7.80
Buy
STOCHRSI (14)
11.88
Buy
MACD (12,26)
-0.01
Sell
ADX (14)
12.19
Buy
Williams %R
-88.12
Buy
CCI (14)
-69.11
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
26.54
Sell
ROC
0.00
Sell
Altamira Therapeutics’s (CYTOF) Relative Strength Index (RSI) is 42.32, creating a Neutral signal.
Altamira Therapeutics’s (CYTOF) Trend Strength Indicator (ADX) is 12.19, creating a Buy signal.
Altamira Therapeutics’s (CYTOF) Commodity Channel Index (CCI) is -69.11, creating a Neutral signal.

FAQ

Is CYTOF a Buy, Hold, or Sell?
Based on CYTOF’s technical indicators, CYTOF is a Strong Sell.
    What is CYTOF’s RSI (14)?
    CYTOF’s RSI (14) is 42.32, which suggests CYTOF is a Neutral.
      What is CYTOF’s MACD?
      CYTOF’s MACD is -0.01, which suggests CYTOF is a Sell.
        What is CYTOF’s 5-day moving average?
        CYTOF’s 5-day moving average is 0.11, which suggests CYTOF is a Sell.
          What is CYTOF’s 20-day moving average?
          CYTOF 20-day moving average is 0.12, which suggests CYTOF is a Sell.
            What is CYTOF’s 50-day moving average?
            CYTOF’s 50-day moving average is 0.15, which suggests CYTOF is a Sell.
              What is CYTOF’s 200-day moving average?
              CYTOF’s 200-day moving average is 0.72, which suggests CYTOF is a Sell.
                What is CYTOF’s Williams % R (14)?
                CYTOF’s Williams % R (14) is -88.12, which suggests CYTOF is a Buy.
                  What is CYTOF’s CCI (14)?
                  CYTOF’s CCI (14) is -69.11, which suggests CYTOF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis